Tag: ischemic heart disease

Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial 1. Patients receiving landiolol were more likely to achieve target heart rates of 60-94 following sepsis-related tachyarrhythmia and had significantly reduced incidence of new onset arrhythmia Evidence Rating: 1...
1. Colchicine given to patients after a myocardial infarction led to a significantly lower risk of death from cardiovascular causes, resuscitations, myocardial infarctions, stroke, and hospitalizations for angina. 2. The main adverse events from colchicine, as compared to placebo, were diarrhea, nausea, and pneumonia. Evidence Rating Level: 1 (Excellent) Study Rundown: The American...
1. Colchicine given to patients after a myocardial infarction led to a significantly lower risk of death from cardiovascular causes, resuscitations, myocardial infarctions, stroke, and hospitalizations for angina. 2. The main adverse events from colchicine, as compared to placebo, were diarrhea, nausea, and pneumonia. Evidence Rating Level: 1 (Excellent) Study Rundown: The...